A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Calliditas Therapeutics Ab stock. As of the latest transaction made, Citadel Advisors LLC holds 8,500 shares of CALT stock, worth $340,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,500
Previous 1,500 466.67%
Holding current value
$340,000
Previous $31,000 967.74%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$20.04 - $25.66 $275,890 - $353,261
13,767 Added 1664.69%
14,594 $306,000
Q4 2023

Feb 14, 2024

SELL
$15.79 - $28.99 $65,228 - $119,757
-4,131 Reduced 83.32%
827 $21,000
Q3 2023

Nov 14, 2023

BUY
$15.68 - $20.38 $59,662 - $77,545
3,805 Added 330.01%
4,958 $90,000
Q2 2023

Aug 14, 2023

BUY
$15.7 - $25.61 $18,102 - $29,528
1,153 New
1,153 $18,000
Q4 2022

Feb 14, 2023

BUY
$11.5 - $19.6 $8,774 - $14,954
763 New
763 $12,000
Q1 2021

May 17, 2021

BUY
$27.01 - $32.92 $258,512 - $315,077
9,571 New
9,571 $264,000
Q3 2020

Nov 16, 2020

SELL
$21.61 - $25.69 $1.37 Million - $1.63 Million
-63,551 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$19.17 - $23.2 $1.22 Million - $1.47 Million
63,551 New
63,551 $1.48 Million

Others Institutions Holding CALT

About Calliditas Therapeutics AB


  • Ticker CALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,624,800
  • Market Cap $1.06B
  • Description
  • Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...
More about CALT
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.